Xenon Pharmaceuticals Inc
XENE
$28.49-0.97 (-3.29%)
May 28, 2025, 4:00 PM
Financials
| 52Week High | 46.00 | 52Week Low | 26.74 |
| Beta | 1.09 | Current Ratio Annual | 17.85 |
| Current Ratio Quarterly | 17.66 | Market Cap | 2.26B |
| Net Profit Margin TTM | -867.29 | Operating Margin TTM | -969.84 |
| Price To Book | 3.21 | Price To Sales TTM | 301.41 |
| Quick Ratio Annual | 17.66 | Quick Ratio Quarterly | 17.43 |
| Return On Assets TTM | -30.84 | Return On Equity TTM | -32.44 |
| Return On Investment TTM | -32.44 | Revenue Per Share TTM | 0.10 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 210 | 0 | 0 | 4 | 3 | 0 | 76.40M | $2.85B |
| Mar 31, 2025 | 210 | 21 | 21 | 69 | 73 | 45 | 77.37M | $2.50B |
| Change | 0(0%) | 21 | 21 | 65(1625%) | 70(2333%) | 45 | 967.50K(1%) | $345.14M(12%) |